Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Articles
|
![]() |
10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100Health & Medicine Week, 2004NewsRX LLCFull text available |
2 |
Material Type: Newsletter Articles
|
![]() |
10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100Biotech Week, 2004, p.390NewsRX LLCFull text available |
3 |
Material Type: Newsletter Articles
|
![]() |
2009 Medco drug trend reportMedical Benefits, 2009, Vol.26 (11), p.1New York: Aspen Publishers, IncFull text available |
4 |
Material Type: Newsletter Articles
|
![]() |
Aadalimumab significantly improves signs and symptoms of joint diseaseHealth & Medicine Week, 2004, p.759NewsRX LLCFull text available |
5 |
Material Type: Newsletter Articles
|
![]() |
Aadalimumab significantly improves signs and symptoms of joint diseaseBiotech Week, 2004, p.17NewsRX LLCFull text available |
6 |
Material Type: Newsletter Articles
|
![]() |
Aadalimumab significantly improves signs and symptoms of joint diseasePharma Business Week, 2004, p.207NewsRX LLCFull text available |
7 |
Material Type: Newsletter Articles
|
![]() |
Aarhus University; One step closer to tailored treatment of severe rheumatic diseasesNewsRx Health & Science, 2020, p.409Atlanta: NewsRxFull text available |
8 |
Material Type: Newsletter Articles
|
![]() |
AAV-based treatment completely suppresses rheumatoid arthritis in animal modelsPharma Business Week, 2004, p.187NewsRX LLCFull text available |
9 |
Material Type: Newsletter Articles
|
![]() |
AAV-based treatment completely suppresses rheumatoid arthritis in animal modelsHealth & Medicine Week, 2004, p.920NewsRX LLCFull text available |
10 |
Material Type: Newsletter Articles
|
![]() |
AbbVie; AbbVie Presents New Data at the European E-Congress of Rheumatology EULAR 2020 Showcasing Depth of its Rheumatology PortfolioPharma Business Week, 2020, p.8Atlanta: NewsRxFull text available |